Trial intelligence / Profile preview

RTA 402 in Obese Adults

NCT04018339Phase 1Completed

Sponsor
Kyowa Kirin
Start
Aug 2019
Primary completion
May 2020
Modality
Classical Binding Small Molecules
Countries
1
01

Overview

Phase 1, randomised, double-blind trial in obesity comparing RTA 402 with Placebo (2 arms). Primary endpoints: Changes from baseline in weight at 6 months, Changes from baseline in fat mass at 6 months and 12 more. Started Aug 2019; status: completed.

02

Drugs

bardoxolone methyl
03

Conditions

obesity

Beyond the preview

Go deeper on NCT04018339.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04018339.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call